| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.83e-04 | 14 | 29 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | ribosomal small subunit binding | 2.73e-04 | 17 | 29 | 2 | GO:0043024 | |
| GeneOntologyBiologicalProcess | mitochondrial translational initiation | 1.91e-06 | 2 | 29 | 2 | GO:0070124 | |
| GeneOntologyBiologicalProcess | import into cell | 8.48e-05 | 1074 | 29 | 8 | GO:0098657 | |
| MousePheno | increased magnesium level | 8.59e-06 | 26 | 22 | 3 | MP:0031659 | |
| MousePheno | increased circulating magnesium level | 8.59e-06 | 26 | 22 | 3 | MP:0010092 | |
| MousePheno | increased creatinine clearance | 1.42e-05 | 4 | 22 | 2 | MP:0005557 | |
| MousePheno | abnormal circulating HDL cholesterol level | 5.85e-05 | 460 | 22 | 6 | MP:0000184 | |
| MousePheno | abnormal magnesium level | 5.95e-05 | 49 | 22 | 3 | MP:0020883 | |
| MousePheno | abnormal circulating magnesium level | 5.95e-05 | 49 | 22 | 3 | MP:0001771 | |
| MousePheno | abnormal magnesium ion homeostasis | 6.32e-05 | 50 | 22 | 3 | MP:0011979 | |
| MousePheno | abnormal circulating lipoprotein level | 1.32e-04 | 533 | 22 | 6 | MP:0010330 | |
| MousePheno | abnormal lipoprotein level | 1.32e-04 | 533 | 22 | 6 | MP:0010329 | |
| MousePheno | abnormal kidney papilla morphology | 3.56e-04 | 18 | 22 | 2 | MP:0004193 | |
| MousePheno | abnormal kidney pyramid morphology | 3.98e-04 | 19 | 22 | 2 | MP:0004192 | |
| MousePheno | increased pancreatic alpha cell number | 4.42e-04 | 20 | 22 | 2 | MP:0009176 | |
| MousePheno | increased circulating HDL cholesterol level | 4.71e-04 | 238 | 22 | 4 | MP:0001556 | |
| Domain | CAC1F_C | 6.50e-06 | 3 | 28 | 2 | PF16885 | |
| Domain | CAC1F_C | 6.50e-06 | 3 | 28 | 2 | IPR031688 | |
| Domain | VDCC_L_a1su | 1.30e-05 | 4 | 28 | 2 | IPR005446 | |
| Domain | GPHH_dom | 4.53e-05 | 7 | 28 | 2 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 4.53e-05 | 7 | 28 | 2 | IPR014873 | |
| Domain | Ca_chan_IQ | 4.53e-05 | 7 | 28 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 4.53e-05 | 7 | 28 | 2 | PF08763 | |
| Domain | GPHH | 4.53e-05 | 7 | 28 | 2 | PF16905 | |
| Domain | VDCCAlpha1 | 9.68e-05 | 10 | 28 | 2 | IPR002077 | |
| Domain | TPR-contain_dom | 1.44e-03 | 150 | 28 | 3 | IPR013026 | |
| Domain | Channel_four-helix_dom | 3.29e-03 | 57 | 28 | 2 | IPR027359 | |
| Domain | - | 3.29e-03 | 57 | 28 | 2 | 1.20.120.350 | |
| Domain | - | 3.58e-03 | 207 | 28 | 3 | 1.25.40.10 | |
| Domain | - | 4.36e-03 | 222 | 28 | 3 | 1.25.10.10 | |
| Domain | TPR-like_helical_dom | 4.99e-03 | 233 | 28 | 3 | IPR011990 | |
| Domain | ARM-like | 7.49e-03 | 270 | 28 | 3 | IPR011989 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 3.80e-05 | 6 | 23 | 2 | M47762 | |
| Pathway | REACTOME_SIGNALING_BY_LTK | 1.39e-04 | 11 | 23 | 2 | MM17235 | |
| Pathway | REACTOME_SIGNALING_BY_LTK | 1.66e-04 | 12 | 23 | 2 | M48256 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.29e-04 | 14 | 23 | 2 | M47692 | |
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 6.71e-07 | 2 | 29 | 2 | 16921373 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 12095986 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 6.71e-07 | 2 | 29 | 2 | 25966695 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 32035616 | ||
| Pubmed | Genetic dissection of horizontal cell inhibitory signaling in mice in complete darkness in vivo. | 2.01e-06 | 3 | 29 | 2 | 26024096 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 20937870 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 12900400 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 28330839 | ||
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 18809727 | ||
| Pubmed | 5.21e-05 | 13 | 29 | 2 | 19209188 | ||
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 20188150 | ||
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 18418385 | ||
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 24453333 | ||
| Pubmed | 8.64e-05 | 1327 | 29 | 7 | 32694731 | ||
| Pubmed | 2.69e-04 | 29 | 29 | 2 | 8617512 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 3.58e-04 | 410 | 29 | 4 | 26949251 | |
| Pubmed | 3.64e-04 | 754 | 29 | 5 | 35906200 | ||
| Pubmed | 3.70e-04 | 34 | 29 | 2 | 35341793 | ||
| Pubmed | 4.39e-04 | 37 | 29 | 2 | 16396496 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.63e-04 | 38 | 29 | 2 | 30786075 | |
| Pubmed | 4.88e-04 | 39 | 29 | 2 | 38690566 | ||
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 7.09e-04 | 47 | 29 | 2 | 19167335 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 7.54e-04 | 1353 | 29 | 6 | 29467282 | |
| Pubmed | 7.88e-04 | 506 | 29 | 4 | 30890647 | ||
| Interaction | CPPED1 interactions | 2.05e-06 | 19 | 27 | 3 | int:CPPED1 | |
| Interaction | IARS2 interactions | 2.78e-05 | 273 | 27 | 5 | int:IARS2 | |
| Interaction | PNPT1 interactions | 3.97e-05 | 145 | 27 | 4 | int:PNPT1 | |
| Interaction | HSDL2 interactions | 4.65e-05 | 151 | 27 | 4 | int:HSDL2 | |
| Interaction | CRYZ interactions | 5.82e-05 | 160 | 27 | 4 | int:CRYZ | |
| Interaction | MRPL43 interactions | 6.56e-05 | 165 | 27 | 4 | int:MRPL43 | |
| Interaction | ADGB interactions | 7.73e-05 | 10 | 27 | 2 | int:ADGB | |
| Interaction | MRPS6 interactions | 8.62e-05 | 177 | 27 | 4 | int:MRPS6 | |
| Interaction | ATP5MF-PTCD1 interactions | 1.20e-04 | 72 | 27 | 3 | int:ATP5MF-PTCD1 | |
| Interaction | MRPL27 interactions | 1.20e-04 | 193 | 27 | 4 | int:MRPL27 | |
| Interaction | PPIA interactions | 1.29e-04 | 888 | 27 | 7 | int:PPIA | |
| Interaction | CTNNBL1 interactions | 1.30e-04 | 197 | 27 | 4 | int:CTNNBL1 | |
| Interaction | ZSCAN2 interactions | 1.34e-04 | 13 | 27 | 2 | int:ZSCAN2 | |
| Interaction | PYCR1 interactions | 1.46e-04 | 203 | 27 | 4 | int:PYCR1 | |
| Interaction | MRPL1 interactions | 1.52e-04 | 205 | 27 | 4 | int:MRPL1 | |
| Interaction | PYCR2 interactions | 1.64e-04 | 209 | 27 | 4 | int:PYCR2 | |
| Interaction | MRPL24 interactions | 1.70e-04 | 211 | 27 | 4 | int:MRPL24 | |
| Interaction | MRPL22 interactions | 1.79e-04 | 214 | 27 | 4 | int:MRPL22 | |
| Interaction | MRPL9 interactions | 1.79e-04 | 214 | 27 | 4 | int:MRPL9 | |
| Interaction | MKI67 interactions | 1.79e-04 | 648 | 27 | 6 | int:MKI67 | |
| Interaction | MOB2 interactions | 2.11e-04 | 87 | 27 | 3 | int:MOB2 | |
| Interaction | MRPL37 interactions | 2.21e-04 | 226 | 27 | 4 | int:MRPL37 | |
| Interaction | MRFAP1 interactions | 2.41e-04 | 91 | 27 | 3 | int:MRFAP1 | |
| Interaction | DHRS2 interactions | 2.57e-04 | 93 | 27 | 3 | int:DHRS2 | |
| Interaction | SPIN4 interactions | 2.61e-04 | 18 | 27 | 2 | int:SPIN4 | |
| Interaction | ERAL1 interactions | 2.65e-04 | 237 | 27 | 4 | int:ERAL1 | |
| Interaction | IBA57 interactions | 2.65e-04 | 94 | 27 | 3 | int:IBA57 | |
| Interaction | LETM1 interactions | 2.69e-04 | 238 | 27 | 4 | int:LETM1 | |
| Interaction | MRPL42 interactions | 2.86e-04 | 242 | 27 | 4 | int:MRPL42 | |
| Interaction | CYP27A1 interactions | 2.91e-04 | 19 | 27 | 2 | int:CYP27A1 | |
| Interaction | TTC39B interactions | 2.91e-04 | 19 | 27 | 2 | int:TTC39B | |
| Interaction | CWC27 interactions | 3.18e-04 | 100 | 27 | 3 | int:CWC27 | |
| Interaction | AKR1C1 interactions | 3.24e-04 | 20 | 27 | 2 | int:AKR1C1 | |
| Interaction | MRPL28 interactions | 3.24e-04 | 250 | 27 | 4 | int:MRPL28 | |
| Interaction | TTI1 interactions | 3.27e-04 | 101 | 27 | 3 | int:TTI1 | |
| Interaction | RAB1B interactions | 3.39e-04 | 253 | 27 | 4 | int:RAB1B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q26 | 7.58e-03 | 207 | 29 | 2 | chr10q26 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.11e-04 | 26 | 21 | 2 | 253 | |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP | 2.79e-06 | 26 | 28 | 3 | M14024 | |
| Drug | Pl-cs | 1.00e-05 | 107 | 29 | 4 | CID006450086 | |
| Drug | Nicotine | 2.53e-05 | 1000 | 29 | 8 | ctd:D009538 | |
| Drug | potassium | 2.68e-05 | 1008 | 29 | 8 | CID000000813 | |
| Drug | Cinnarizine | 5.61e-05 | 9 | 29 | 2 | DB00568 | |
| Drug | Nimodipine | 5.61e-05 | 9 | 29 | 2 | DB00393 | |
| Drug | isobutanol | 6.68e-05 | 62 | 29 | 3 | CID000006560 | |
| Drug | gallopamil | 8.43e-05 | 67 | 29 | 3 | CID000001234 | |
| Drug | Mibefradil | 8.55e-05 | 11 | 29 | 2 | DB01388 | |
| Drug | NSC759576 | 9.67e-05 | 191 | 29 | 4 | CID000003075 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 4.47e-06 | 4 | 26 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Hearing Loss, Extreme | 1.40e-04 | 20 | 26 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 1.40e-04 | 20 | 26 | 2 | C0581883 | |
| Disease | Deaf Mutism | 1.40e-04 | 20 | 26 | 2 | C4082305 | |
| Disease | Prelingual Deafness | 1.40e-04 | 20 | 26 | 2 | C0011052 | |
| Disease | Bilateral Deafness | 1.40e-04 | 20 | 26 | 2 | C3665473 | |
| Disease | Deafness, Acquired | 1.40e-04 | 20 | 26 | 2 | C0751068 | |
| Disease | Primary microcephaly | 1.71e-04 | 22 | 26 | 2 | C0431350 | |
| Disease | Deafness | 2.21e-04 | 25 | 26 | 2 | C0011053 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 4.62e-04 | 36 | 26 | 2 | DOID:11723 (implicated_via_orthology) | |
| Disease | feeling miserable measurement | 2.21e-03 | 79 | 26 | 2 | EFO_0009598 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQKKWKIMKKAALLI | 1986 | Q8IZT6 | |
| WKALKKVNMKLLVNI | 246 | Q3KRB8 | |
| GRIQKDWKKLVQMKI | 231 | Q9H3S7 | |
| RIVIKKIWKRMKQKL | 1551 | O60840 | |
| VITKAGMKLKWSKLK | 141 | P46199 | |
| LILVKQKKWQGLQEM | 446 | P29376 | |
| QWIKKKHLVQITIKK | 181 | Q9H2K0 | |
| NKAVKNVIKKLWKQI | 286 | A6NMZ5 | |
| KEKNVTLLWKPLMKN | 656 | P48357 | |
| KKVWIGIKKLLMLIE | 701 | P46459 | |
| LKLLAMAKLWKKQQQ | 816 | Q9BZJ0 | |
| VKDICQAIWKLKKVM | 376 | Q86XA9 | |
| WIKNMEKANKLAVIK | 3091 | Q8TD57 | |
| QVKIWFQNRRMKLKK | 311 | Q9NYD6 | |
| MKVNFLKPNLKVNLW | 811 | Q9Y2H2 | |
| VIKKIWKKTSMKLLD | 1576 | Q01668 | |
| VKVQLMLNQRKWKKR | 281 | Q8NBV8 | |
| NVISKSQLKNIKKMW | 56 | O43776 | |
| MKVVNLKQAILQAWK | 1 | O75448 | |
| GMAKKQAWLIKNKIK | 731 | Q13621 | |
| MKKWVESITKIIQRK | 726 | Q07889 | |
| LIQMKSIWKKKQKNQ | 141 | I1YAP6 | |
| LARISLVKKLMKKWS | 81 | Q0VAA5 | |
| LVKKLMKKWSVTQNL | 86 | Q0VAA5 | |
| KLWNIMEKQGLKTSK | 821 | Q8N394 | |
| QWKKISAIIEKRKKM | 531 | Q13123 | |
| SKRQMKKLIKQKQWE | 41 | Q8TBZ6 | |
| SMKLHNLISKLKKWI | 3431 | Q9Y4A5 | |
| LKKWIKILEAKTKQL | 3441 | Q9Y4A5 | |
| KLKQIKNRMKKTDWL | 251 | Q9UGI0 | |
| ILIIAAKWLQKMKEK | 126 | A6NI61 |